BIII 890

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIII 890, covering 2014-09-29 to 2014-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke [Phase 2]